A digital neuroscience company has announced a new strategic partnership with the University of Bristol.
Cambridge Cognition, whicch creates software to monitor brain health and detect brain health conditions, announced the partnership.
The work is intended to accelerate the development of the company’s brain health products.
“We are delighted to extend and formalise our relationship with the talented team at the University of Bristol,” said Dr Jenny Barnett, Chief Scientific Officer, Cambridge Cognition.
“Working more closely will enable us to build a pipeline of novel, evidence-based and usable tools to better measure and monitor mental health across all ages groups and accelerate our ability to validate our digital health apps in a clinical setting.”
A team at the University of Bristol, led by Professor Marcus Munafò, will bring its expertise in mental health and addiction, and a network of patient groups and clinicians to the partnership.
“This is an exciting opportunity to rapidly translate our research into clinical practice and patient benefit,” Professor Marcus Munafò, Professor of Biological Psychology, University of Bristol.
“We have worked with Cambridge Cognition for several years and this partnership allows us to extend this work and build on their experience of digital neuroscience.”
The company recently announced a new £500,000 contract with a major pharmaceutical company.